Precursor Cell Lymphoblastic Leukemia-Lymphoma
"Precursor Cell Lymphoblastic Leukemia-Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
| Descriptor ID |
D054198
|
| MeSH Number(s) |
C04.557.337.428.600 C15.604.515.560.600 C20.683.515.528.600
|
| Concept/Terms |
Precursor Cell Lymphoblastic Leukemia-Lymphoma- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor Cell Lymphoblastic Leukemia Lymphoma
- Leukemia, Acute Lymphoblastic
- Acute Lymphoblastic Leukemia
- Leukemia, Lymphoblastic
- Leukemia, Lymphoblastic, Acute
- Leukemia, Lymphocytic, Acute
- Lymphoblastic Leukemia
- Lymphoblastic Leukemia, Acute
- Lymphoblastic Lymphoma
- Lymphocytic Leukemia, Acute
- Acute Lymphocytic Leukemia
- Leukemia, Acute Lymphocytic
- Lymphoma, Lymphoblastic
- Acute Lymphoid Leukemia
- Leukemia, Acute Lymphoid
- Lymphoid Leukemia, Acute
- Leukemia, Lymphoid, Acute
Leukemia, Lymphocytic, Acute, L1- Leukemia, Lymphocytic, Acute, L1
- Lymphocytic Leukemia, L1
- L1 Lymphocytic Leukemia
- Leukemia, L1 Lymphocytic
- Lymphoblastic Leukemia, Acute, Childhood
- Lymphoblastic Leukemia, Acute, L1
- ALL, Childhood
- Childhood ALL
- Leukemia, Lymphoblastic, Acute, L1
Leukemia, Lymphocytic, Acute, L2- Leukemia, Lymphocytic, Acute, L2
- Lymphocytic Leukemia, L2
- L2 Lymphocytic Leukemia
- Leukemia, L2 Lymphocytic
- Lymphoblastic Leukemia, Acute, Adult
- Lymphoblastic Leukemia, Acute, L2
- Leukemia, Lymphoblastic, Acute, L2
- Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
|
Below are MeSH descriptors whose meaning is more general than "Precursor Cell Lymphoblastic Leukemia-Lymphoma".
Below are MeSH descriptors whose meaning is more specific than "Precursor Cell Lymphoblastic Leukemia-Lymphoma".
This graph shows the total number of publications written about "Precursor Cell Lymphoblastic Leukemia-Lymphoma" by people in this website by year, and whether "Precursor Cell Lymphoblastic Leukemia-Lymphoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 4 | 6 |
| 1997 | 2 | 2 | 4 |
| 1998 | 8 | 0 | 8 |
| 1999 | 7 | 1 | 8 |
| 2000 | 8 | 0 | 8 |
| 2001 | 5 | 0 | 5 |
| 2002 | 5 | 1 | 6 |
| 2003 | 7 | 2 | 9 |
| 2004 | 6 | 0 | 6 |
| 2005 | 10 | 0 | 10 |
| 2006 | 4 | 0 | 4 |
| 2007 | 9 | 0 | 9 |
| 2008 | 8 | 2 | 10 |
| 2009 | 8 | 1 | 9 |
| 2010 | 7 | 2 | 9 |
| 2011 | 6 | 1 | 7 |
| 2012 | 7 | 0 | 7 |
| 2013 | 5 | 0 | 5 |
| 2014 | 4 | 2 | 6 |
| 2015 | 5 | 1 | 6 |
| 2016 | 12 | 1 | 13 |
| 2017 | 8 | 0 | 8 |
| 2018 | 12 | 1 | 13 |
| 2019 | 13 | 0 | 13 |
| 2020 | 16 | 0 | 16 |
| 2021 | 17 | 0 | 17 |
| 2022 | 20 | 0 | 20 |
| 2023 | 10 | 0 | 10 |
| 2024 | 8 | 1 | 9 |
| 2025 | 7 | 1 | 8 |
| 2026 | 12 | 0 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Precursor Cell Lymphoblastic Leukemia-Lymphoma" by people in Profiles.
-
Improved outcomes with TKI maintenance after brexucabtagene autoleucel in Philadelphia chromosome ALL. Blood Adv. 2026 09 08; 10(17):5821-5827.
-
Consensus recommendations for CAR T-cell administration in adult acute lymphoblastic leukemia: a modified Delphi study. Blood. 2026 08 06; 148(6):657-668.
-
Toxicity from asparaginase during acute lymphoblastic leukemia induction: a report from the Children's Oncology Group. Blood Adv. 2026 07 28; 10(14):4923-4930.
-
Adolescents and Young Adults With Acute Lymphoblastic Leukemia: Qualitative Barriers and Facilitators to Guideline-Concordant Care. Cancer Control. 2026 Jan-Dec; 33:10732748261469238.
-
American Society of Hematology 2026 guidelines for management of relapsed/refractory acute lymphoblastic leukemia in adolescents and young adults. Blood Adv. 2026 Jul 14; 10(13):4726-4756.
-
American Society of Hematology 2026 guidelines for frontline management of acute lymphoblastic leukemia in adolescents and young adults. Blood Adv. 2026 Jul 14; 10(13):4671-4708.
-
Updates in Childhood Acute Lymphoblastic Leukemia. Hematol Oncol Clin North Am. 2026 06; 40(3):331-346.
-
Pediatric-inspired regimens and HSCT for adolescents and young adults with acute lymphoblastic leukemia. Blood Adv. 2026 May 26; 10(10):3664-3675.
-
Incorporating ALL Biology into Treatment Decisions: Next Steps toward Targeted Therapy in Adult ALL. Blood Cancer Discov. 2026 05 05; 7(3):369-379.
-
Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Leuk Lymphoma. 2026 Jun; 67(7):1587-1594.